Drug Formulation 2022

Drug Formulation 2022

About Conference:

ME Conferences is honored to invite participants from all around the world to the "14th Annual Congress on Drug Formulation & Analytical Techniques" to explore their knowledge in their various surgical specialties.

The DRUG FORMULATION 2022 is a two-day event that will feature an exhibition or workshop at the conference to highlight new research and developing technologies. The conference includes a variety of sessions, such as Keynote, Oral, YRF (student presentation), poster, and e-poster presentations. Eminent speakers and delegates from all around the world are attending the conference to give their insightful presentations on their most current research work, as well as advanced methodologies, advances, and the most recent updates related to Drug Formulation.

Why Should You Attend?

DRUG FORMULATION 2022 welcomes people from all over the world who are interested in learning more about Drug Formulation and Analytical Techniques. The best signs of this gathering include widely regarded presenters, the latest systems, and the most recent improvements in Research and Development. It also allows a wide spectrum of scientists to communicate with one another.

“14th Annual Congress on Drug Formulation & Analytical Techniques” provides a forum for Chemists, researchers, practitioners, and educators to put their education, training, and talents to good use while also discussing the most recent breakthroughs, practical issues, and solutions in the field of Drug Formulation & Analytical Techniques.

Target Audience:

  • PhD Scholars
  • Graduates and Post Graduates
  • Directors, CEO’s of Organizations
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Software development companies
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • CRO and DATA management Companies
  • Training Institutes
  • Business Entrepreneur
  • Government healthcare departments, HTA’s and drug regulators
  • Digital health companies
  • Genomics and personalised medicine experts
  • Professors, Associate Professors, Assistant Professors

Track 1: Pharmaceutical Formulations

Pharmaceutical formulation is the process of combining various chemical elements, including the drug, to develop a finished medicinal product in pharmaceutics. Formulation studies entail creating a medicine formulation that is both stable and acceptable to the patient. This usually ensures converting the drug into a tablet or capsule for oral administration. The drug's formulations show that it is compatible with these additional substances.

Track 2: Formulation Research and Development

The drug exposed to drug development undergoes number of trials and are tested at different stages to produce a final potent therapeutic designed for the treatment of various disorders. Various qualities are evaluated during this process to determine whether the medicine is non-toxic to biological systems and therapeutic. The active ingredients are compounded into final dose form using appropriate excipients and technical processes.

Track 3: Clinical Trials

A subtype of pharmacological absorption is bioavailability. The area under the plasma concentration–time curve is commonly used to determine bioavailability. Pharmaceutics variables, physicochemical features of the medicine, Dosage form characteristics & Pharmaceutical Ingredients, Patient-related factors such as age, Routes of administration (Parenteral, Rectal, Oral, and Topical), and so on all affect bioavailability.

Track 4: Clinical Research

A BA study allows for the evaluation of the effect of route of administration on patient and then determination of the absolute BA of the drug released from the drug product. The BA for a certain formulation indicates the percentage of the orally supplied dose that is absorbed into the systemic circulation. Absolute Bioavailability is the term used when the reference standard is an IV dosage. Relative Bioavailability is used when the reference standard is any other dose form than IV.

Track 5: Pharmaceutical Freeze Drying Technology

The removal of ice or other frozen solvents from a substance by sublimation and the removal of bound water molecules by desorption are both examples of pharmaceutical freeze technology. Depending on the industry and area where the drying is taking place, the terms lyophilization and freeze drying are interchangeable. Controlled freeze drying maintains a low enough product temperature throughout the process to prevent changes in the dried product's look and properties.

  • Sublimation
  • Pharmaceutical freeze technology
  • Lyophilization
  • Freeze drying
  • Bound water

Track 6: Nanomedicine & Nanotechnology

Nanotechnology is the study of very small structures with sizes ranging from 0.1 to 100 nanometers. Nanomedicine is a relatively new scientific and technological field. A brief overview of the several types of pharmaceutical nanosystems is provided. The dimensions of nanomaterials are used to classify them. Nanotechnology is discussed in depth in a variety of sectors, including health and medical, electronics, energy, and the environment.

  • Nanoparticles
  • Peptide delivery
  • Nanosystems
  • Carbon nanotubes
  • Alzheimer's

Track 7: Analytical Method Development and Validation

The process of selecting an accurate assay procedure to identify the composition of a formulation is known as analytical method development. It's the process of demonstrating that an analytical method is suitable for use in a lab to determine the concentration of subsequent samples. Analytical techniques must be produced using the protocols and acceptance conditions outlined in the ICH recommendations and repurposed within GMP and GLP environments.

Track 8: Pharmaceuticals Regulatory Affairs

Regulatory affairs (RA), sometimes known as government affairs, are a career path in regulated industries like pharmaceuticals, medical devices, energy, banking, and telecommunications. Within the healthcare industry, regulatory affairs have a very specific connotation (pharmaceuticals, medical devices, biologics and functional foods). Regulatory affairs (medical affairs) specialists (sometimes known as regulatory professionals) are in charge of the following areas:

Track 9: NMR and Small Organic Molecule Analysis

A coffee mass (900 Daltons [1]) compound incapable of facilitating process regulation, with a size on the order of 109 m, is a small grade molecule in bioscience and pharmaceuticals. The majority of drug tests are identical small compounds. The following devices should be utilised for the examination of tiny organic molecules: HPLC technique, chromatography, ultraviolet-visible (UV-VIS) spectrophotometry, infrared (IR) spectroscopy, and mass spectrometry.

Track 10:  Role of chemistry in Pharmaceuticals

Pharmaceutical science is a significant area of study. It entails a variety of scientific disciplines that are used to develop pharmaceutical medication molecules. Computational chemistry is used to create new chemical compounds that can be used as medications. Medicinal and organic chemistry are both used in the manufacturing of pharmaceutical medications. Analytical chemistry is concerned with pharmaceutical quality control and analysis.

Track 11: Industrial Pharmacy

Industrial pharmacy is also important in the development of new drugs. The industrial method is critical for every breakthrough drug discovery to achieve widespread commercial application. Supply chain, waste management, product management, post-marketing surveillance, good manufacturing methods, and marketing are some of the factors that industries must address in order to supply safe and cost-effective medicine to patients.

Track 12: Shelf Life & Stability Studies

It entails creating a drug preparation that is both stable and agreeable to patients, which is required for drug product marketing approval. Stability studies are carried out at various stages of the drug development cycle for a variety of reasons, with the ultimate goal of bringing a stable medication to market. Drug formulation stability studies are undertaken during the development phase to support formulation development, safety, and efficacy claims of investigational novel medicines.

  • Shelf-life
  • Package configuration
  • Stability studies
  • Drug formulation stability
  • Novel medicines

Track 13: Novel Drug Delivery System

In 1970, the phrase "drug delivery system" was coined to characterise a set of technologies that were utilised to develop finished drug products that were not intended for rapid distribution. Drug release, absorption, distribution, and elimination processes are all designed to improve product efficacy; drug delivery technologies alter safety, patient convenience, and compliance. The most common routes of medication administration are the oral and parenteral routes, but alternate drug delivery is preferred in many situations.

Track 14: Drug Formulation Procedures

Pharmaceutical formulation Procedures will take a number of trials and screening at various stages so as to generate potent drug for the treatment of several diseases. After going through the different stages, the candidate found most suitable drug for the purpose is selected. Drug Formulation 2016 China is going to cover wide and interesting topics like this.

Track 15: Computer Aided Drug Design ( CADD )

The use of bioinformatics tools to build novel drugs has opened up a new avenue of drug research and development. We can use computational tools to find drug targets and design drugs. In the following drug design path, bioinformatics has an impact on a new drug design.

Track 16: Biomarkers in Drug Design

Researchers have been able to discover an increasing number of significant molecular drivers of cancer growth because to advancements in cancer molecular characterisation technology. Multiple innovative anticancer therapies have resulted from these drug discoveries, as well as clinical benefits in some patient groups. Despite this, clinically useful prognostic biomarkers of response are still being identified.

Track 17: Traditional Medicine Design

Traditional medicine is a collection of extensive knowledge, skills, and practises based on theories, beliefs, and experiences that are unique to various cultures, whether or not they are explicable. However, it is used to maintain health as well as to prevent, diagnose, and treat physical and mental disorders. Traditional medicine refers to medical parts of traditional knowledge that have been passed down through generations in diverse communities prior to the advent of modern medicine.

  • Traditional medicine
  • Novel therapeutic targets (PDTs)
  • Mental disorders
  • Modern medicine
  • Cancer

Track 18: Pharmacokinetics

The study of the time course of medication absorption, distribution, metabolism, and excretion is known as pharmacokinetics. The application of pharmacokinetic concepts to the safe and effective therapeutic management of medications in a single patient is known as clinical pharmacokinetics. Clinical pharmacokinetics' main goals are to improve the efficacy and reduce the toxicity of a patient's medication therapy.

Track 19: Novel Approaches to Analytical and Bio analytical Methods

The study of the separation, identification, quality control, and quality assurance of chemical parts of natural and manmade materials is known as analytical chemistry. The preservation of a desired degree of quality in an exceptionally packaged or product, notably via the application of resources to each stage of the delivery or production technique. Bio analytical chemistry is a sub-discipline of analytical chemistry that deals with the measurement of pharmaceuticals, ions, proteins, and DNA sequences in non-natural substances or concentrations.

Track 20: Advances in Chromatography and Mass Spectrometry

Organic substances are analysed using chromatography and mass qualitative analysis. In mass spectroscopic analysis, electro spray ionisation (ESI) could be used. As far as chromatography and mass spectrometry are concerned. HPLC is also versatile, educational, and well-respected by industry professionals. Recent advancements in sample preparation techniques have helped overcome challenges faced with LC-MS processing of small compounds from bio fluids.

  • Organic substances
  • Electro spray ionisation (ESI)
  • Mass spectrometry
  • Bio analysis
  • Chromatography

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 17-18, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View